---

In the 1980s, the author conducted extensive studies in which, for the first time in medicine, he provided evidence of the impressive immune activation in active fever therapy in humans.

---

Fever is a physiological and holistic process. It activates a complex immune defence network and can also be used successfully as a therapeutic principle for malignant and chronic diseases. In addition to the increase in temperature, which serves as an amplifier mechanism for the rapid activation of immunological reactions, the central fever mediator, interleukin-1 (formerly endogenous pyrogen), triggers extensive immune reactions as a real immune cascade.
In the 1980s, the author conducted extensive studies in which, for the first time in medicine, he provided evidence of the impressive immune activation in active fever therapy in humans, which is based on therapy with Coley´s MBV (mixed bacterial vaccines).
The efficiency of the therapy with Coley´s toxins was confirmed by the convincing immunological and clinical results.These remarks are also a tribute to the courageous and creative physician William Bradley Coley (1862-1936), the "Godfather of Immunotherapy" .
His work was evaluated by his daughter Helen Coley Nauts (1907-2001), who founded the Cancer Research Institute in New York in 1953. During the years of his clinical activity, the author had conducted lively scientific and personal correspondence with her.

---

Göhring, Einar
Born in 1946 in Rothenburg o.T., 1966 study of chemistry in Würzburg, from 1969 medical studies in Göttingen. 1976 doctorate at the Institute of Forensic Medicine, 1977 licensure. Medical training in several hospitals. From 1977 assistant and senior physician at the Ringbergklinik Dr. Issels in Bad Wiessee, from 1981 at the Ringbergklinik Rottach-Egern and oncological practice of Issels in Bad Wiessee until 1982. In 1983, together with his wife, founding the Aeskulap-Klinik for Holistic Medicine (specialist clinic for oncological and chronic diseases) in Bad Rappenau; chief physician until the end of operations in September 1988; clinical research and publications on the subject of ¯fever therapy and immune reactions®. Today the author mainly lives abroad.

---